Etanercept formulations stabilized with sodium chloride
First Claim
Patent Images
1. A stable aqueous etanercept formulation comprising 25 to 75 mg/ml of etanercept, up to 150 mM sodium chloride, 1 to 30 mM sodium phosphate, and 3 to 5 wt. % sucrose, wherein the formulation is free of arginine.
5 Assignments
0 Petitions
Accused Products
Abstract
The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
-
Citations
11 Claims
- 1. A stable aqueous etanercept formulation comprising 25 to 75 mg/ml of etanercept, up to 150 mM sodium chloride, 1 to 30 mM sodium phosphate, and 3 to 5 wt. % sucrose, wherein the formulation is free of arginine.
- 6. A stable aqueous etanercept formulation comprising 25 to 75 mg/ml of etanercept, up to 150 mM sodium chloride, 10 to 25 mM sodium phosphate, and 3 to 5 wt. % trehalose, wherein the formulation is free of arginine.
Specification